Recombinant interferon alfa-2b (Shanghai Hua Xin High Biotechnology)

重组人干扰素α2b（上海华新生物高技术有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant interferon alfa-2b (Shanghai Hua Xin High Biotechnology)

Drug Alias NameRecombinant interferon alfa-2b (vaginal), Shanghai Hua Xin High Biotechnology IncXin Fu NingInterferon alfa-2b (Shanghai Hua Xin High Biotechnology)Interferon alpha-2b (Shanghai Hua Xin High Biotechnology)Recombinant interferon alpha-2b (vaginal), Shanghai Hua Xin High Biotechnology Inc +[6]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsUterine Cervical Erosion

Global Approved IndicationsUterine Cervical Erosion

Approved Indications in ChinaUterine Cervical Erosion

Original Approved Country/TerritoryMainland China

Original Approved Date2003/03/11

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesShanghai Huaxin Biotechnology Inc

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Huaxin Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsUterine Cervical Erosion

Inactive IndicationsN/A

Other Information

ATC CodeL03AB05